Advertisement

Stroke

Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines.

Feb 14, 2022

Empiric strategies for secondary prevention in cryptogenic stroke and cryptogenic TIA are lacking. The best therapy to prevent recurrence depends on the cause of stroke. Attempting a correct diagnosis...

Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey.

Feb 07, 2022

To evaluate the association between inflammatory bowel disease (IBD) and atherosclerotic cardiovascular disease (ASCVD) and whether this association is modified by age or sex.We conducted a cross-sect...

The false positive troponin results: case studies of analytical interference.

Jan 31, 2022

Cardiac troponin I and T are particularly sensitive and specific markers for cardiomyocyte damage. Myocardial injury can occur due to a discrepancy between oxygen supply and demand (eg coronary artery...

Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke.

Dec 27, 2021

The risk of major adverse cardiovascular events is substantially increased following a stroke. Although exercise-based cardiac rehabilitation has been shown to improve prognosis following cardiac even...

Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score.

Dec 27, 2021

We hypothesized that cannabis use is associated with cardiovascular disease (CVD) risk factors. This could explain the reported link between cannabis and cardiovascular events including stroke and myo...

Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registry.

Dec 20, 2021

The aim of the study was to report the clinical experience, 30-day mortality and acute outcomes of patients undergoing transcatheter aortic valve implantation (TAVI) in the Asia Pacific region.The Asi...

Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis.

Dec 13, 2021

: The 2018 American Heart Association/ American College of Cardiology Multisociety (AHA/ACC/MS) cholesterol guideline states that statin therapy may be withheld or delayed among intermediate risk indi...

Unsupervised Learning for Automated Detection of Coronary Artery Disease Subgroups.

Dec 06, 2021

Background The promise of precision population health includes the ability to use robust patient data to tailor prevention and care to specific groups. Advanced analytics may allow for automated detec...

Aspirin in the Modern Era of Cardiovascular Disease Prevention.

Nov 29, 2021

Aspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its traditional use as a core therapy for secondary prevention of CVD is well reco...

Impact of Lipoprotein(a) Levels on Perioperative Outcomes in Cardiac Surgery.

Nov 29, 2021

Altered lipid metabolism has been shown to be of major importance in a range of metabolic diseases, with particular importance in cardiovascular disease (CVD). As a key metabolic product, altered lipo...

The Exact Definition of the Boundary between the Rapid and Slow Ejection Phases on ECGs and Accurate Location of the j Point.

Nov 22, 2021

was to describe the boundary between the phases of rapid and slow ejection in the cardiac cycle and to define the exact location of the j point on ECGs.The work is based on the theory of heart cycle ...

Yosprala: Coordinated Delivery of a Proton Pump Inhibitor and Aspirin.

Nov 15, 2021

Review the pharmacology, pharmacokinetics, efficacy, and safety of Yosprala (aspirin and omeprazole). A literature search was conducted using PubMed with the terms "Yosprala," "PA8140," and "PA32540...

Surgical aortic valve replacement in the era of transcatheter aortic valve implantation: a review of the UK national database.

Nov 01, 2021

To date the reported outcomes of surgical aortic valve replacement (SAVR) are mainly in the settings of trials comparing it with evolving transcatheter aortic valve implantation. We set out to examine...

Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management.

Oct 18, 2021

Hypertrophic cardiomyopathy (HCM) is a genetically acquired disease of cardiac myocytes. Studies show that 70% of this disease is a result of different mutations in various sarcomere genes. This revie...

Depression Linked With Risks of Vascular Disease & Mortality in MS

Oct 11, 2021

“Depression is the most frequent comorbidity for people with MS, affecting more than 20% of this patient population,” explains Raffaele Palladino, MD, PhD. “In addition, depression is associated...

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients.

Oct 11, 2021

Stroke prevention and rate or rhythm control are crucial in the management of atrial fibrillation (AF). There is recent evidence for benefit of early rhythm control, yet rate control is the first choi...

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease.

Oct 11, 2021

The 2018 American Heart Association/American College of Cardiology (AHA/ACC) Blood Cholesterol Guideline recommendation to classify patients with atherosclerotic cardiovascular disease (ASCVD) as very...

Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation.

Oct 04, 2021

Percutaneous left atrial appendage occlusion (LAAO) is an alternative nonpharmacological therapeutic option for stroke prevention in patients with NVAF. However, no data exist on potential LAAO candid...

Transcatheter Aortic Valve Replacement With Self-Expandable Supra-Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry.

Sep 20, 2021

Background Transcatheter aortic valve replacement with supra-annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves. The next generation self-expanding...

Bleeding risk in patients with cardiac disease from ischaemic stroke reperfusion therapy: an update.

Sep 13, 2021

Intravenous tissue plasminogen activator (rtPA) and arterial endovascular therapy (ET) rapidly restore cerebral perfusion in eligible patients who had an acute ischaemic stroke (AIS). It is unknown wh...